Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 24618336

Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2014 Apr
First author
Judson I

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Apr;15(4):366-7. doi: 10.1016/S1470-2045(14)70114-7.
    note
    Source null
    related pmid
    24694628
    relationship
    Comment in

Authors and identifiers

  1. name
    Judson I
    type
    Author
  2. name
    Verweij J
    type
    Author
  3. name
    Gelderblom H
    type
    Author
  4. name
    Hartmann JT
    type
    Author
  5. name
    Schöffski P
    type
    Author
  6. name
    Blay JY
    type
    Author
  7. name
    Kerst JM
    type
    Author
  8. name
    Sufliarsky J
    type
    Author
  9. name
    Whelan J
    type
    Author
  10. name
    Hohenberger P
    type
    Author
  11. name
    Krarup-Hansen A
    type
    Author
  12. name
    Alcindor T
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Judson I
    type
    Author
  2. name
    Verweij J
    type
    Author
  3. name
    Gelderblom H
    type
    Author
  4. name
    Hartmann JT
    type
    Author
  5. name
    Schöffski P
    type
    Author
  6. name
    Blay JY
    type
    Author
  7. name
    Kerst JM
    type
    Author
  8. name
    Sufliarsky J
    type
    Author
  9. name
    Whelan J
    type
    Author
  10. name
    Hohenberger P
    type
    Author
  11. name
    Krarup-Hansen A
    type
    Author
  12. name
    Alcindor T
    type
    Author
bibliography ids
  1. nci-bib-15247d5a3445ad89376a9251
book metadata
content sha256
b81c050b5ae007dee9ef9053e1aa98e239eaa2c086e1b9579d122a1a70b03aed
document type
citation
dois
  1. 10.1016/S1470-2045(14)70063-4
electronic publication date
display
2014 Mar 5
precision
day
year
2014
evidence scope
bibliographic_metadata_only
id
pubmed:24618336
immutable id
pubmed:24618336@b81c050b5ae007dee9ef9053e1aa98e239eaa2c086e1b9579d122a1a70b03aed
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
4
name
The Lancet. Oncology
nlm unique id
100957246
pages
415-23
volume
15
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2014 Apr;15(4):366-7. doi: 10.1016/S1470-2045(14)70114-7.
    note
    Source null
    related pmid
    24694628
    relationship
    Comment in
outcomes validated
false
pmid
24618336
provenance
batch id
063b6c38419f18d4021f
provider
NCBI PubMed ESummary
record sha256
35220290cb8571b926f3cabab4a5b902fccf4efd94d01cc410adfc40742d9a0f
response sha256
5abcae41e9384a85f92695ef76b244ffd933f07a58a51082c160af8743d196ad
retrieved at
2026-09-09T23:47:02.607425+00:00
publication date
display
2014 Apr
precision
month
year
2014
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/24618336/
title
Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial.

Preserved source evidence · Not medical advice